Brief: EQL Pharma: Aripiprazol EQL Pharma Approved By The Swedish Medicines Agency For Sale

EQL Pharma AB

25/09/2019 06:29

Sept 25 (Reuters) - EQL Pharma AB  EQL.TE :
    * SAID ON TUESDAY ARIPIPRAZOL EQL PHARMA APPROVED
    * PHARMACEUTICAL ARIPIPRAZOLE EQL PHARMA, ORAL SOLUTION 1MG
/ ML,
HAS BEEN APPROVED BY THE SWEDISH MEDICINES AGENCY FOR SALE
    * ARIPIPRAZOLE EQL PHARMA IS A PRESCRIPTION DRUG USED TO
TREAT
SCHIZOPHRENIA IN ADULTS AND ADOLESCENTS FROM THE AGE OF 15 YEARS
    * PRODUCT IS EXPECTED TO BE LAUNCHED DURING THE FIRST
QUARTER,
2020

    
 Source text for Eikon:  urn:newsml:reuters.com:*:nNDL6bw0rJ
 Further company coverage:  EQL.TE  
   
    
    

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 7720920;))